EichorEICHOR
Study identifier: NCT05668754 Synced from ClinicalTrials.gov · August 02, 2026
● Completed

Study of SDX in Patients With Idiopathic Hypersomnia (IH)

Condition: Idiopathic Hypersomnia  ·  Sponsor: Zevra Therapeutics

PhasePhase 2
Planned participants66
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This is a study of the safety, efficacy and pharmacokinetics (PK) of Serdexmethylphenidate (SDX) compared to placebo in subjects with Idiopathic Hypersomnia (IH).

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (41)

Sleep Disorders Center Of AlabamaBirmingham, Alabama, United States
Amr DaphneDaphne, Alabama, United States
Lakeview Clinical ResearchGuntersville, Alabama, United States
SOCAL Clinical ResearchHuntington Beach, California, United States
Stanford UniversityRedwood City, California, United States
Sleep Medicine Specialists of CaliforniaSan Ramon, California, United States
SDS Clinical Trials, IncSanta Ana, California, United States
Delta Waves, Inc.Colorado Springs, Colorado, United States
Saint Francis Sleep Allergy and Lung Institute LLCClearwater, Florida, United States
New Generation of Medical TrialsHialeah, Florida, United States
Angels Clinical ResearchMiami, Florida, United States
Ivetmar Medical GroupMiami, Florida, United States

+ 29 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →